Home > Research > Publications & Outputs > The effect of untargeted naloxone distribution ...

Links

Text available via DOI:

View graph of relations

The effect of untargeted naloxone distribution on opioid overdose outcomes

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

The effect of untargeted naloxone distribution on opioid overdose outcomes. / Dowd, William N.
In: Health Economics, Vol. 32, No. 12, 02.11.2023.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

APA

Vancouver

Dowd WN. The effect of untargeted naloxone distribution on opioid overdose outcomes. Health Economics. 2023 Nov 2;32(12). Epub 2023 Sept 5. doi: 10.1002/hec.4755

Author

Bibtex

@article{70c6c6015d1842c7a789f1ebc1691631,
title = "The effect of untargeted naloxone distribution on opioid overdose outcomes",
abstract = "Opioid overdose has claimed the lives of over 340,000 Americans in the last decade. Over that same period, policymakers have taken steps to increase the availability of naloxone-an opioid antagonist used to rescue overdose victims-to people in the community. Previous studies, most of which have examined the effects of state laws designed to facilitate access to naloxone, have reached mixed conclusions about the effects of naloxone access on fatal and non-fatal overdoses. This paper exploits a unique policy experiment provided by two naloxone giveaways intended to increase naloxone possession among the general public in Pennsylvania to estimate the causal impact of naloxone distribution on fatal overdoses and opioid-related emergency department (ED) visits. Using a difference-in-differences design, I find evidence that opioid overdose deaths fell immediately following the first giveaway but increased following the second giveaway and discuss these apparently contradictory findings in the context of the changing composition of the opioid supply. I also find some evidence of a decline in opioid overdose-related ED visits following the giveaways. This study is the first to examine the effects of untargeted naloxone distribution and has implications for other novel, naloxone distribution efforts currently underway. [Abstract copyright: {\textcopyright} 2023 The Authors. Health Economics published by John Wiley & Sons Ltd.]",
keywords = "harm reduction, opioid overdose, public health, naloxone",
author = "Dowd, {William N.}",
year = "2023",
month = nov,
day = "2",
doi = "10.1002/hec.4755",
language = "English",
volume = "32",
journal = "Health Economics",
issn = "1057-9230",
publisher = "John Wiley and Sons Ltd",
number = "12",

}

RIS

TY - JOUR

T1 - The effect of untargeted naloxone distribution on opioid overdose outcomes

AU - Dowd, William N.

PY - 2023/11/2

Y1 - 2023/11/2

N2 - Opioid overdose has claimed the lives of over 340,000 Americans in the last decade. Over that same period, policymakers have taken steps to increase the availability of naloxone-an opioid antagonist used to rescue overdose victims-to people in the community. Previous studies, most of which have examined the effects of state laws designed to facilitate access to naloxone, have reached mixed conclusions about the effects of naloxone access on fatal and non-fatal overdoses. This paper exploits a unique policy experiment provided by two naloxone giveaways intended to increase naloxone possession among the general public in Pennsylvania to estimate the causal impact of naloxone distribution on fatal overdoses and opioid-related emergency department (ED) visits. Using a difference-in-differences design, I find evidence that opioid overdose deaths fell immediately following the first giveaway but increased following the second giveaway and discuss these apparently contradictory findings in the context of the changing composition of the opioid supply. I also find some evidence of a decline in opioid overdose-related ED visits following the giveaways. This study is the first to examine the effects of untargeted naloxone distribution and has implications for other novel, naloxone distribution efforts currently underway. [Abstract copyright: © 2023 The Authors. Health Economics published by John Wiley & Sons Ltd.]

AB - Opioid overdose has claimed the lives of over 340,000 Americans in the last decade. Over that same period, policymakers have taken steps to increase the availability of naloxone-an opioid antagonist used to rescue overdose victims-to people in the community. Previous studies, most of which have examined the effects of state laws designed to facilitate access to naloxone, have reached mixed conclusions about the effects of naloxone access on fatal and non-fatal overdoses. This paper exploits a unique policy experiment provided by two naloxone giveaways intended to increase naloxone possession among the general public in Pennsylvania to estimate the causal impact of naloxone distribution on fatal overdoses and opioid-related emergency department (ED) visits. Using a difference-in-differences design, I find evidence that opioid overdose deaths fell immediately following the first giveaway but increased following the second giveaway and discuss these apparently contradictory findings in the context of the changing composition of the opioid supply. I also find some evidence of a decline in opioid overdose-related ED visits following the giveaways. This study is the first to examine the effects of untargeted naloxone distribution and has implications for other novel, naloxone distribution efforts currently underway. [Abstract copyright: © 2023 The Authors. Health Economics published by John Wiley & Sons Ltd.]

KW - harm reduction

KW - opioid overdose

KW - public health

KW - naloxone

U2 - 10.1002/hec.4755

DO - 10.1002/hec.4755

M3 - Journal article

VL - 32

JO - Health Economics

JF - Health Economics

SN - 1057-9230

IS - 12

ER -